Home > News > Altair Nanotechnologies to Present at the Wall Street Analyst Forum
February 25th, 2004
Altair Nanotechnologies to Present at the Wall Street Analyst Forum
Altair Nanotechnologies Inc. announced today that its President, Dr. Rudi Moerck, will be presenting to members of the financial community at the Wall Street Analyst Forum's Pharmaceutical Conference in New York City on March 1, 2004. Dr. Moerck will provide an overview of Altair Nanotechnologies' technology platform along with an in depth discussion and update of the company's patent-pending pharmaceutical, RenaZorb™. Additionally, Dr. Moerck will discuss the company's new nano-based drug delivery system that may possess properties that reduce the potential for the abuse of narcotics.
NanoTechnology for Defense (NT4D) October 22nd, 2014
Mechanism behind nature's sparkles revealed October 22nd, 2014
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014